Shares outstanding of BioAmber Inc.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various chemical market customers primarily in the United States and Canada. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into chemicals that are replacements for petroleum-derived chemicals. The company's bio-succinic acid is used in various applications, including plasticizers, polyurethanes, personal care products, resins and coatings, de-icing solutions, PET resins, lubricants, polybutylene succinate, fine chemicals, and food additives. Its product pipeline also includes bio-succinic acid derivatives, such as 1, 4 butanediol and tetrahydrofuran used in elastomers, engineering plastics, shoe soles, spandex, and solvents; succinic acid based polyesters for use in automotive interiors, fibers and non-wovens, food packaging, plastic bags and cups, and organic composite boards; and C6 building block chemicals comprising adipic acid, caprolactam, and hexamethylenediamine used in carpets, engineering plastics, textiles and fibers, films, and polyurethanes. The company was formerly known as DNP Green Technology, Inc. and changed its name to BioAmber Inc. in September 2010. BioAmber Inc. is headquartered in Montreal, Canada.
|PFNX Pfenex Inc.||NYSEMKT > Health Care > Major Pharmaceuticals||-255.87%|
|ADMA ADMA Biologics Inc||NASDAQ > Health Care > Biotechnology: Biological Products (No Diagnostic Substances)||-250.87%|
|OHGI One Horizon Group, Inc.||NASDAQ > Public Utilities > Telecommunications Equipment||-247.78%|
|JAG Jagged Peak Energy Inc.||NYSE > Energy > Oil & Gas Production||-246.94%|
|AVIR Aviragen Therapeutics, Inc.||NASDAQ > Health Care > Biotechnology: Biological Products (No Diagnostic Substances)||-243.59%|
|PRAN Prana Biotechnology Ltd||NASDAQ > Health Care > Major Pharmaceuticals||-239.05%|
|BIOA BioAmber Inc.||NYSE > Basic Industries > Major Chemicals||-238.42%|
|ASG Liberty All-Star Growth Fund, Inc.||NYSE > Finance > Closed-End Fund - Equity||2,321.85%|
|WMIH WMIH Corp.||NASDAQ > Finance > Finance: Consumer Services||2,450.53%|
|INVT Inventergy Global, Inc.||NASDAQ > Technology > Telecom Services - Domestic||2,494.79%|
|LBRDA Liberty Broadband Corporation||NASDAQ > Consumer Services > Television Services||15,533.66%|
|LBRDK Liberty Broadband Corporation||NASDAQ > Consumer Services > Television Services||15,533.66%|
|CNCE Concert Pharmaceuticals, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||122,824.66%|